| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/10/2007 | US20070104708 Compositions, methods, and kits relating to resistin |
| 05/10/2007 | US20070104647 Ovr115 antibody compositions and methods of use |
| 05/10/2007 | DE102005051977A1 Neue 2,4-Dichlorphenoxyessigsäurederivate und deren Verwendung in diagnostischen und analytischen Nachweisverfahren New 2.4-dichlorophenoxyacetate and their use in diagnostic and analytical detection method |
| 05/10/2007 | CA2628221A1 Compositions and methods for diagnosing and treating cancer |
| 05/10/2007 | CA2627891A1 Uses of anti-cd40 antibodies |
| 05/10/2007 | CA2627890A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 05/10/2007 | CA2627427A1 Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions |
| 05/10/2007 | CA2617723A1 Novel cxc-chemokine antagonists |
| 05/10/2007 | CA2603775A1 Method of protecting against staphylococcal infection |
| 05/09/2007 | EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 05/09/2007 | EP1783224A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/09/2007 | EP1783221A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 05/09/2007 | EP1783218A1 Hcv rna having novel sequence |
| 05/09/2007 | EP1783142A1 Mouse monoclonal antibody recognizing acetyllysine, labeled antibody and utilization of the same |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1782833A2 pH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 05/09/2007 | EP1782806A1 Compositions for treating dermatological and neurological disorders |
| 05/09/2007 | EP1781826A2 Compositions and methods for diagnosis and treatment of orthopoxviruses |
| 05/09/2007 | EP1781803A2 Production of anti-amyloid beta antibodies |
| 05/09/2007 | EP1781788A2 Chicken deoxycytidine and deoxyadenosine kinase enzymes and their use |
| 05/09/2007 | EP1781705A2 Interferon alpha receptor i antibodies and their uses |
| 05/09/2007 | EP1781704A2 Antibodies directed against amyloid-beta peptide and methods using same |
| 05/09/2007 | EP1781703A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 05/09/2007 | EP1781699A1 Multimers of peptides |
| 05/09/2007 | EP1781682A1 B7-h5, a costimulatory polypeptide |
| 05/09/2007 | EP1781328A1 Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby |
| 05/09/2007 | EP1781321A1 A method of treating cancer comprising a vegf-b antagonist |
| 05/09/2007 | EP1781269A2 IgE-RETARGETING, FUNCTION-ALTERING MOLECULES (ERFAM) FOR TREATMENT OF ALLERGIC DISEASES |
| 05/09/2007 | EP1781267A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 05/09/2007 | EP1731530A9 A kind of fusion protein, gene encoding it, expression method and use thereof |
| 05/09/2007 | EP1689779A4 Native immunoglobulin binding reagents and methods for making and using same |
| 05/09/2007 | EP1573031A4 Androgen regulated nucleic acid molecules and encoded proteins |
| 05/09/2007 | EP1554579A4 Methods of secretory vimentin detection and modulation |
| 05/09/2007 | EP1456663B1 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 05/09/2007 | EP1254169B1 Methods relating to modulation of th2 cell subset activity by modulation of xbp-1 activity |
| 05/09/2007 | EP1212431B1 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 05/09/2007 | EP1169058B1 Insulin-like growth factor binding protein-4 protease |
| 05/09/2007 | EP1140968B9 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 05/09/2007 | EP0998486B1 Protein recovery by chromatography followed by filtration upon a charged layer |
| 05/09/2007 | EP0960212B1 Gene identification method |
| 05/09/2007 | EP0782625B1 Expression and export technology of proteins as immunofusins |
| 05/09/2007 | EP0692029B1 Genetically engineered glutaminase and its use in therapy |
| 05/09/2007 | CN1961076A Methods to make and use antibodies of improved cross-reactivity |
| 05/09/2007 | CN1961073A Truncated DANCE, DANCE complex and method of using these |
| 05/09/2007 | CN1961071A Methods and constructs for expressing polypeptide polymers in eukaryotic cells using alternative splicing |
| 05/09/2007 | CN1961004A Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent |
| 05/09/2007 | CN1961003A Humanized anti-TGF-beta antibodies |
| 05/09/2007 | CN1961002A Binding molecules capable of neutralizing rabies virus and uses thereof |
| 05/09/2007 | CN1960756A Cytotoxicity mediation of cells evidencing cell membrane surface expression of CD63 |
| 05/09/2007 | CN1960755A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 05/09/2007 | CN1960754A Cancer regulation antibody |
| 05/09/2007 | CN1960753A Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis |
| 05/09/2007 | CN1960750A Therapeutic use of anti-CS1 antibodies |
| 05/09/2007 | CN1958615A Antibody of anti human CD20 from human resources functionally, and application |
| 05/09/2007 | CN1958614A Fusion protein of chemoattracting small peptide and dual specific antibodies |
| 05/09/2007 | CN1958613A Mucinl antibody and usage |
| 05/09/2007 | CN1958612A MUC5AC antibody and usage |
| 05/09/2007 | CN1958611A Mucin antibody in sera, and usage |
| 05/09/2007 | CN1958610A Medication of guiding antibody for anti leukaemia in monocarpotic cellularity |
| 05/09/2007 | CN1958609A Triad high immune immunoglobulin for anti colibacillosis of pigs |
| 05/09/2007 | CN1958608A Method for preparing specificity IgY of anti influenza of birds, and preparation |
| 05/09/2007 | CN1314965C Method of determining immunology |
| 05/09/2007 | CN1314806C Miniaturized polypeptide of anti EB Virus tumour, application and preparation method |
| 05/09/2007 | CN1314803C Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 05/09/2007 | CN1314707C 2, 4, 6-trichlorophen artificial antigen, and its preparing method and use |
| 05/09/2007 | CN1314450C Multicomponent vaccines |
| 05/08/2007 | USRE39614 Canine IL-4 immunoregulatory proteins and uses thereof |
| 05/08/2007 | US7214851 Bzip type transcription factors regulating the expression of rice storage protein |
| 05/08/2007 | US7214790 Genes and proteins encoded thereby |
| 05/08/2007 | US7214785 isolating novel anti-FVIII inhibitor antibodies distinctly having specificity and the inhibitor activity to FVIII from lymphocytes of a patient by the antibody display phage technology and analyzed the VH and VL chains of said specific antibodies |
| 05/08/2007 | US7214781 Using syndecan and collagen biomarkers detect in blood or nontumorous tissue to diagnose cancer |
| 05/08/2007 | US7214777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/08/2007 | US7214776 Antibody fragment-polymer conjugates and uses of same |
| 05/08/2007 | US7214775 Method of modulating the activity of functional immune molecules |
| 05/08/2007 | US7214772 Sialoadhesin family member-2 (SAF-2) |
| 05/08/2007 | US7214533 Polynucleotide useful for modulating cancer cell proliferation |
| 05/08/2007 | US7214512 Genomic mammary Amyloid a sequence |
| 05/08/2007 | US7214499 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
| 05/08/2007 | US7214495 Screening method |
| 05/08/2007 | US7214493 For therapy of cancer |
| 05/08/2007 | US7214483 KCNQ2 and KCNQ3—potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies |
| 05/08/2007 | US7214479 E. coli O157:H7 C1-INH-binding protein and methods of use |
| 05/08/2007 | US7214376 Methods of inhibiting TNFα in patients with neoplastic disease |
| 05/08/2007 | US7214375 Providing an antibody to suppress the activity of transforming growth factor; contacting the tissue with the anti-TGF- beta antibody that binds to TGF- beta |
| 05/08/2007 | US7214374 12832, a novel human kinase-like molecule and uses thereof |
| 05/08/2007 | US7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 05/08/2007 | US7214372 Culture regeneration of nervous systems; cell differentiation; wound healing agent |
| 05/08/2007 | US7214367 Orally-administered interferon-tau compositions and methods |
| 05/08/2007 | CA2385872C Gene transfer in human lymphocytes using retroviral scfv cell targeting |
| 05/03/2007 | WO2007051169A2 Use of b cell expansion agents in generating antibodies |
| 05/03/2007 | WO2007051164A2 Toll like receptor 3 modulators, methods and uses |
| 05/03/2007 | WO2007050798A2 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer |
| 05/03/2007 | WO2007050359A2 Anti-addl monoclonal antibody and use thereof |
| 05/03/2007 | WO2007049805A1 Synthetic lipopeptide and use thereof for medical purposes |
| 05/03/2007 | WO2007049770A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 05/03/2007 | WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same |
| 05/03/2007 | WO2007049472A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 05/03/2007 | WO2007049044A1 Siglec-9 binding agents |
| 05/03/2007 | WO2007049017A2 Agents that bind a target in pulmonary tissue for treating respiratory diseases |